Canaccord Genuity Maintains Buy on Compass Pathways, Lowers Price Target to $48
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity maintains a Buy rating on Compass Pathways (NASDAQ:CMPS) but lowers the price target from $50 to $48.
August 02, 2024 | 11:46 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Canaccord Genuity maintains a Buy rating on Compass Pathways but lowers the price target from $50 to $48.
The Buy rating suggests continued confidence in the stock, but the lowered price target indicates a slightly less optimistic outlook. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100